Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report

This postmarketing surveillance study assessed the safety and effectiveness of teriparatide in patients with osteoporosis at high risk of fracture in Japan. The patients received teriparatide 20 μg daily by subcutaneous injection, for a maximum of 24 months. Safety and effectiveness analyses were ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Atsushi, Ishida, Takehiro, Taketsuna, Masanori, Yoshiki, Fumito, Enomoto, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939987/
https://www.ncbi.nlm.nih.gov/pubmed/27462147
http://dx.doi.org/10.2147/CIA.S107285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939987/
https://www.ncbi.nlm.nih.gov/pubmed/27462147
http://dx.doi.org/10.2147/CIA.S107285

Ejemplares similares